Edgestream Partners, L.P. Abbott Laboratories Transaction History

Edgestream Partners, L.P.

$2.23 Billion
Q3 2024

A detailed history of Edgestream Partners, L.P. transactions in Abbott Laboratories stock. As of the latest transaction made, Edgestream Partners, L.P. holds 16,293 shares of ABT stock, worth $1.87 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

16,293

Previous 15,987 1.91%

Holding current value

$1.87 Million

Previous $1.66 Million 11.8%

% of portfolio

0.08%

Previous 0.08%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $30,621 - $36,147	306 Added 1.91%	16,293 $1.86 Million
Q2 2024 Aug 09, 2024	BUY	$100.73 - $112.44 $1.35 Million - $1.5 Million	13,353 Added 506.95%	15,987 $1.66 Million
Q1 2024 May 10, 2024	SELL	$109.52 - $120.96 $2.97 Million - $3.28 Million	-27,110 Reduced 91.14%	2,634 $299,000
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $1.55 Million - $1.89 Million	17,155 Added 136.27%	29,744 $3.27 Million
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $805,795 - $966,819	-8,435 Reduced 40.12%	12,589 $1.22 Million
Q2 2023 Aug 10, 2023	SELL	$100.78 - $112.29 $3.09 Million - $3.44 Million	-30,636 Reduced 59.3%	21,024 $2.29 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $1.6 Million - $1.89 Million	16,556 Added 47.16%	51,660 $5.23 Million
Q4 2022 Feb 13, 2023	BUY	$95.06 - $111.52 $3.13 Million - $3.67 Million	32,923 Added 1509.54%	35,104 $3.85 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $1.73 Million - $2 Million	-17,857 Reduced 89.12%	2,181 $211,000
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $851,672 - $1.03 Million	-8,344 Reduced 29.4%	20,038 $2.18 Million
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $1.88 Million - $2.29 Million	16,476 Added 138.38%	28,382 $3.36 Million
Q4 2021 Feb 15, 2022	SELL	$115.53 - $141.46 $251,508 - $307,958	-2,177 Reduced 15.46%	11,906 $1.68 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $3.01 Million - $3.33 Million	-25,795 Reduced 64.68%	14,083 $1.66 Million
Q2 2021 Aug 10, 2021	SELL	$105.79 - $124.53 $377,458 - $444,323	-3,568 Reduced 8.21%	39,878 $4.62 Million
Q1 2021 May 06, 2021	BUY	$108.84 - $128.23 $4.73 Million - $5.57 Million	43,446 New	43,446 $5.21 Million
Q3 2020 Nov 10, 2020	SELL	$91.64 - $111.29 $7.82 Million - $9.5 Million	-85,357 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$76.57 - $98.0 $834,306 - $1.07 Million	10,896 Added 14.63%	85,357 $7.8 Million
Q1 2020 May 14, 2020	BUY	$62.82 - $91.86 $1.09 Million - $1.59 Million	17,319 Added 30.31%	74,461 $5.88 Million
Q4 2019 Feb 13, 2020	SELL	$78.51 - $87.4 $849,870 - $946,105	-10,825 Reduced 15.93%	57,142 $4.96 Million
Q3 2019 Nov 08, 2019	BUY	$81.84 - $88.74 $5.21 Million - $5.65 Million	63,661 Added 1478.43%	67,967 $5.69 Million
Q2 2019 Aug 08, 2019	SELL	$72.88 - $85.0 $2.32 Million - $2.71 Million	-31,890 Reduced 88.1%	4,306 $362,000
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $2.4 Million - $2.9 Million	36,196 New	36,196 $2.89 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Edgestream Partners, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Edgestream Partners, L.P. with notifications on news.

Account

Edgestream Partners, L.P. Abbott Laboratories Transaction History